Characteristics of sudden death in hemodialysis patients

Kidney International

Volumn 69, Issue 12, 2006, Pages 2268-2273

  Bleyer, A J ^a   Hartman, J ^a   Brannon, P C ^a   Reeves Daniel, A ^a   Satko, S G ^a   Russell, G ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular; Hemodialysis; Peritoneal dialysis; Sudden death; Survival

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; POTASSIUM;

ADULT; ARTICLE; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DRUG USE; FEMALE; FREQUENCY ANALYSIS; HEALTH CENTER; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOTHESIS; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD; PATIENT MONITORING; POTASSIUM BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING; STATISTICAL ANALYSIS; SUDDEN DEATH;

ADRENERGIC BETA-ANTAGONISTS; AGED; CORONARY ARTERIOSCLEROSIS; DEATH, SUDDEN; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPOKALEMIA; MALE; MASS SCREENING; MIDDLE AGED; POTASSIUM; PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 33745080012     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000446     Document Type: Article

References (35)

1. Table H.16 Death Rates by Primary Cause of Death: Dialysis Patients, Unadjusted, in USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, edited by U.S. Renal Data System, Bethesda, MD, 2003, p 484.
2. Kannel WB, Schatzkin A. Sudden death: lessons from subsets in population studies. J Am Coll Cardiol 1985; 5: 141B-149B.
3. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999; 55: 1553-1559.
4. Franklin B, Bonzheim K, Gordon S, Timmis G. Snow shoveling: a trigger for acute myocardial infarction and sudden coronary death. Am J Cardiol 2004; 77: 855-858.
5. Morrison G, Michelson EL, Brown S, Morganroth J. Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients. Kidney Int 1980; 17: 811-819.
6. Lorincz I, Matyus J, Zilahi Z et al. QT dispersion in patients with end-stage renal failure and during hemodialysis. J Am Soc Nephrol 1999; 10: 1297-1302.
7. Cupisti A, Galetta F, Caprioli R et al. Potassium removal increases the QTc Interval dispersion during hemodialysis. Nephron 1999; 82: 122-126.
8. Morris S, Galiatsou E, Stewart G et al. QT dispersion before and after hemodialysis. J Am Soc Nephrol 1999; 10: 160-163.
9. Karnik JA, Young BS, Lew NL et al. Cardiac arrest and sudden death in dialysis units. Kidney Int 2001; 60: 350-357.
10. Ifudu O, Reydel K, Vlacich V et al. Dietary potassium is not the sole determinant of serum potassium concentration in hemodialysis patients. Dial Transplant 2004; 33: 684-693.
11. Bleyer AJ. Sudden death in dialysis patients. Cardiac Electro-Physiol Rev 2001; 5: 419-421.
12. Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 2001; 38: S11-S17.
13. Zoccali C, Mallamaci F, Parlongo S et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2004; 105: 1354-1359.
14. Converse RL, Jacobsen TN, Jost CMT et al. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest 1992; 90: 1657-1665.
15. Muller J, Kaufmann P, Luepker R et al. Mechanisms precipitating acute cardiac arrest: review and recommendations of an NHLBI workshop. Circulation 1997; 96: 3233-3239.
16. Dorian P. Antiarrhythmic actions of beta-blockers: potential mechanisms. J Cardiovasc Pharmacol Ther 2005; 10: S15-S22.
17. Ponce SP, Jennings AE, Madias NE, Harrington JT. Drug induced hyperkalemia. Medicine 1985; 64: 357-370.
18. Arrizabalaga P, Montolium J, Martinez VA et al. Increase in serum potassium caused by beta-2 adrenergic blockage in terminal renal failure: absence of mediation by insulin or aldosterone. Proc Eur Dial Transplant Assoc 1983; 20: 572-576.
19. Allon M. Treatment and prevention of hyperkalemia in end-stage renal disease. Kidney Int 1993; 43: 1197-1209.
20. Zehender M, Faber T, Koscheck U et al. Ventricular tachyarrhythmias, myocardial ischemia, and sudden cardiac death in patients with hypertensive heart disease. Clin Cardiol 1995; 18: 377-383.
21. Johnston R, de Bono D, Nyman C. Preventable sudden death in patients receiving angiotensin converting enzyme inhibitors and loop/potassium sparing diuretic combinations. Int J Cardiol 1992; 34: 213-215.
22. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999; 55: 1553-1559.
23. Bleyer AJ, Tell GS, Evans GW et al. Survival of patients undergoing renal replacement therapy in one center with special emphasis on racial differences. Am J Kidney Dis 1996; 28: 72-81.
24. Abbott KC, Glanton CW, Trespalacios FC et al. Body mass index, dialysis modality, and survival: analysis of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study. Kidney Int 2004; 65: 597-605.
25. Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 2003; 42: 201-208.
26. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure. Lancet 1999; 353: 2001-2007.
27. Cice G, Ferrara L, Di Benedetto A et al. Dilated cardiomyopathy in dialysis patients - beneficial efects of carvedilol: a double-blind, placebo-controlled trial. J Am Coll Cardiol 2001; 37: 407-411.
28. Koch M, Thomas B, Tschope W, Ritz E. Survival and predictors of death in dialysed diabetic patients in Europe. Diabetologia 1993; 36: 1113-1117.
29. Herzog CA, Muster HA, Li S, Collins AJ. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail 2004; 10: 467-472.
30. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248.
31. Cheung AK, Levin NW, Agodoa L et al. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003; 14: 3251-3263.
32. Panigua R, Amato D, Vonesh E et al. Mexican Nephrology Collaborative Study Group. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307-1320.
33. Hinkle LE, Thaler HT. Clinical classification of cardiac deaths. Circulation 1982; 65: 457-464.
34. Willich SN, Levy D, Rocco MB et al. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987; 60: 801-806.
35. Popovtzer MM, Knochel JP, Kumar R. Disorders of calcium, phosphorus, vitamin D, and parathyroid hormone activity, chapter 6. In: Schrier RW (ed). Renal and Electrolyte Disorders, 5th edn. Lippincott-Raven: Philadelphia, PA, 2004, pp 241-319.